• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

The use of psychedelics has been a long-standing topic of interest in the fields of psychology, neuroscience, and pharmacology, with these substances having been used for centuries in various cultures for their therapeutic and metaphysical properties. In recent years, there has been a renewed interest in the research and development of psychedelics as potential treatments for mental health disorders, such as existential dread, psilocybe truffles anxiety, and post-traumatic stress disorder (PTSD).

From a pharmacological perspective, psychedelics act on the brain's neurotransmitter systems, especially the serotonin system, to produce their effects. Serotonin is a neurotransmitter that plays a crucial role in regulating mood and reality processing. Psychedelics, such as psilocybin, are classified as neurotransmitter-regulating agents, meaning they interact with the serotonin receptors in the brain.

Psilocybin, the active compound in psychedelic fungi, is a potent repressor of the serotonin transporter, a protein that regulates the reuptake of serotonin from synapses. By blocking this protein, psilocybin increases the amount of serotonin available in the synaptic cleft, where it can bind to serotonin receptors and produce its outcomes. These effects include modifications in cognitive processes, such as motions in time and space perception, and increased feelings of self-insight.

LSD, on the other hand, is a non-selective serotonin receptor agonist, meaning it binds to multiple serotonin receptors with equal affinity, producing a broad range of outcomes. LSD is known to bind to the 5-HT2A receptor, which is involved in the control of perception and consciousness. Activation of this receptor is thought to play a role to the psychedelic effects of LSD, including motions in visual perception, visions, and altered sense of self.

DMT, a short-acting psychedelic, is produced endogenously in the brain as a neurotransmitter and is also found in various plants and animals. DMT is thought to interact with the 5-HT2A receptor in a similar fashion as LSD, producing profound perceptual modifications and altered states of consciousness.

In contrast to other psychoactive substances, such as opioids and benzodiazepines, psychedelics have a relatively low abuse potential and are typically not associated with physical dependence. This is thought to be due to their distinct mode of operation, which involves activation of serotonin receptors rather than gabaergic systems, which are more commonly associated with dependence.